Literature DB >> 10914794

Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis.

V I Haraszthy1, G Hariharan, E M Tinoco, J R Cortelli, E T Lally, E Davis, J J Zambon.   

Abstract

BACKGROUND: Actinobacillus actinomycetemcomitans leukotoxin is thought to be an important virulence factor in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. Some highly leukotoxic A. actinomycetemcomitans strains produce 10 to 20 times more leukotoxin than other minimally leukotoxic strains. The distribution, clonality, and intrafamilial transmission of highly leukotoxic A. actinomycetemcomitans were examined in order to determine the importance of leukotoxin in the pathogenesis of periodontitis.
METHODS: The polymerase chain reaction (PCR) was used to differentiate highly leukotoxic from minimally leukotoxic strains in examining 1,023 fresh A. actinomycetemcomitans isolates and strains from our culture collection. These were obtained from 146 subjects including 71 with localized juvenile periodontitis (LJP), 4 with early-onset periodontitis, 11 with post-localized juvenile periodontitis, 41 with adult periodontitis, and 19 periodontally normal subjects. The arbitrarily primed polymerase chain reaction (AP-PCR) analysis of 30 oral isolates from each of 25 subjects was used to determine the intraoral distribution of A. actinomycetemcomitans clones. AP-PCR was also used to examine the transmission of A. actinomycetemcomitans in 30 members of 6 families. The clonality of 41 highly leukotoxic A. actinomycetemcomitans strains was evaluated by both AP-PCR and ribotyping.
RESULTS: Highly leukotoxic A. actinomycetemcomitans was found only in subjects with localized juvenile and early-onset periodontitis. Fifty-five percent of the LJP subjects harbored highly leukotoxic A. actinomycetemcomitans isolates. Seventy-three percent of the A. actinomycetemcomitans isolates in these subjects were highly leukotoxic. Highly leukotoxic A. actinomycetemcomitans infected younger subjects (mean age 13.95 years, range 5 to 28 years) than minimally leukotoxic (mean age 35.47 years, range 6 to 65 years). Most subjects were infected with only one A. actinomycetemcomitans genotype. However, PCR of whole dental plaques and subsequent analysis of up to 130 individual oral isolates suggested a possible shift in A. actinomycetemcomitans over time in that a few subjects harbored both highly leukotoxic and minimally leukotoxic strains. AP-PCR analysis was consistent with intrafamilial A. actinomycetemcomitans transmission. Ribotyping and AP-PCR analysis confirmed a previous report that highly leukotoxic A. actinomycetemcomitans consists of a single clonal type.
CONCLUSIONS: This study suggests that localized juvenile and other forms of Actinobacillus-associated periodontitis are primarily associated with the highly leukotoxic clone of A. actinomycetemcomitans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914794     DOI: 10.1902/jop.2000.71.6.912

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  49 in total

1.  Population structure and genetic diversity of Actinobacillus actinomycetemcomitans strains isolated from localized juvenile periodontitis patients.

Authors:  Jeffrey B Kaplan; Helen C Schreiner; David Furgang; Daniel H Fine
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Improved PCR for detection of the highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans in subgingival plaque samples.

Authors:  Knud Poulsen; Oum-Keltoum Ennibi; Dorte Haubek
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

3.  Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652.

Authors:  Christine Mitchell; Ling Gao; Donald R Demuth
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  P Kelk; R Claesson; L Hänström; U H Lerner; S Kalfas; A Johansson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.

Authors:  Nataliya V Balashova; Juan A Crosby; Lourdes Al Ghofaily; Scott C Kachlany
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 6.  Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells.

Authors:  M Handfield; H V Baker; R J Lamont
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

7.  Novel loop-mediated isothermal amplification method for detection of the JP2 clone of Aggregatibacter actinomycetemcomitans in subgingival plaque.

Authors:  Mitsuko Seki; Knud Poulsen; Dorte Haubek; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

8.  Leukotoxicity of Aggregatibacter actinomycetemcomitans in generalized aggressive periodontitis in Brazilians and their family members.

Authors:  Virginia Régia Souza Silveira; Márcia Viana Bessa Nogueira; Nádia Accioly Pinto Nogueira; Vilma Lima; Flávia Aparecida Chaves Furlaneto; Rodrigo Otávio Rego
Journal:  J Appl Oral Sci       Date:  2013 Sep-Oct       Impact factor: 2.698

Review 9.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

10.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.